Previous Close | 2.8000 |
Open | 2.7900 |
Bid | 2.7900 x 800 |
Ask | 2.8000 x 1300 |
Day's Range | 2.7400 - 2.8200 |
52 Week Range | 2.0200 - 7.2000 |
Volume | |
Avg. Volume | 1,068,704 |
Market Cap | 216.646M |
Beta (5Y Monthly) | 1.73 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.7330 |
Earnings Date | Jul 26, 2022 - Aug 01, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 17.56 |
Subscribe to Yahoo Finance Plus to view Fair Value for VKTX
Intercept (ICPT) faces yet another setback as its resubmission for NDA for OCA for NASH gets delayed.
Viewing insider transactions for Viking Therapeutics, Inc.'s ( NASDAQ:VKTX ) over the last year, we see that insiders...
Pfizer (PFE) obtains Fast Track designation for its investigational combination therapy - ervogastat and clesacostat for the treatment of NASH.